Robert Charles Seeger, MD

Title(s)Professor of Pediatrics
AddressCHL Mail Stop 57
Off Campus
Los Angeles CA 90089
Phone+1 323 361 5618
vCardDownload vCard
    Other Positions
    Title(s)Section Head for Research in the Division of HemOncBMT

    Collapse Biography 
    Collapse Awards and Honors
    University of Southern California School2011Mellon Mentoring Award
    Willamette University2008Distinguished Alumni Citation
    2001H. Russell Smith Award for Innovation in Pediatric Biomedical Research

    Collapse Overview 
    Collapse Overview
    Dr. Seeger is Professor of Pediatrics in the Keck School of Medicine, Director of Cancer Research Program of the Saban Research Institute, and Division Head for Basic and Translational Research of the Center for Cancer and Blood Diseases at CHLA. Dr. Seeger obtained MD and MS degrees from the University of Oregon School of Medicine, Pediatric training at the University of Minnesota, and research training at the NIH and University College London. Before joining USC in 1989 as a Professor of Pediatrics, he was Professor of Pediatrics at the UCLA School of Medicine.

    He is a well-funded investigator and currently is the Principal Investigator of a PPG, an R01, an R33, and two U10s. Dr. Seeger’s therapeutic research deals with immunotherapy strategies that seek to maximize natural killer (NK) cell activity with tumor cell targeting antibodies and with agents that modify the tumor microenvironment milieu to minimize NK suppressive effects of monocytes/macrophages producing IL-6 and TGFß1. His biomarker research, in collaboration with Dr. Shahab Asgharzadeh, has resulted in a 14-gene expression signature (TaqMan® Low Density Array, TLDA) that predicts outcome for children with high-risk metastatic neuroblastoma. He also has developed a second TLDA assay that quantifies expression of 5 neuroblastoma genes in bone marrow and blood with the ability to detect 1 tumor cell/million normal cells. This assay is proving useful for monitoring response and predicting outcome.

    Finally, in his role as Principal Investigator of and NCI-funded Neuroblastoma PPG, he Co-Chairs the Scientific Review Committee of the New Approaches to Neuroblastoma Therapy consortium (NANT, see www.nant.org), which sets directions and reviews clinical trial proposals. The NANT is an early-phase clinical trials consortium of 15 institutions in North America that tests new treatments, biomarkers, and imaging for children with refractory or recurrent neuroblastoma. Thus, his expertise includes pre-clinical immunotherapy, biomarker development and application, and early phase clinical trials.

    Collapse Research 
    Collapse Research Activities and Funding
    Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
    NIH/NCI P01CA217959Sep 18, 2017 - Aug 31, 2022
    Role: Principal Investigator
    Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
    NIH/NCI R01CA182633Mar 4, 2014 - Feb 28, 2017
    Role: Co-Principal Investigator
    Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
    NIH/NCI R33CA152809Sep 1, 2010 - Aug 31, 2013
    Role: Principal Investigator
    Biology and Therapy of High Risk Neuroblastoma
    NIH/NCI P01CA081403Jul 6, 2000 - May 31, 2015
    Role: Principal Investigator
    Clinical Correlative Studies of Neuroblastoma
    NIH/NCI R01CA060104Aug 1, 1993 - Sep 28, 2007
    Role: Principal Investigator
    NIH/NCI U01CA060104Aug 1, 1993 - May 31, 1997
    Role: Principal Investigator
    NIH/NCI R03CA053329Sep 30, 1990 - Sep 29, 1992
    Role: Principal Investigator
    NIH/NCI R01CA022794Feb 1, 1978 - May 31, 1997
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells. Clin Cancer Res. 2019 08 01; 25(15):4761-4774. Wu HW, Sheard MA, Malvar J, Fernandez GE, DeClerck YA, Blavier L, Shimada H, Theuer CP, Sposto R, Seeger RC. PMID: 31068371.
      View in: PubMed   Mentions: 1     Fields:    
    2. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracell Vesicles. 2019; 8(1):1588538. Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY. PMID: 30891164.
      View in: PubMed   Mentions:
    3. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms. Cancer Res. 2019 03 15; 79(6):1151-1164. Neviani P, Wise PM, Murtadha M, Liu CW, Wu CH, Jong AY, Seeger RC, Fabbri M. PMID: 30541743.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    4. Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma. Clin Cancer Res. 2019 01 01; 25(1):325-333. Barry WE, Jackson JR, Asuelime GE, Wu HW, Sun J, Wan Z, Malvar J, Sheard MA, Wang L, Seeger RC, Kim ES. PMID: 30232225.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    5. Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1641. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 30046297.
      View in: PubMed   Mentions: 1     Fields:    
    6. A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1355. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 29967609.
      View in: PubMed   Mentions: 4     Fields:    
    7. Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma. Clin Cancer Res. 2018 11 15; 24(22):5673-5684. Wei JS, Kuznetsov IB, Zhang S, Song YK, Asgharzadeh S, Sindiri S, Wen X, Patidar R, Najaraj S, Walton A, Auvil JMG, Gerhard DS, Yuksel A, Catchpoole D, Hewitt SM, Sondel PM, Seeger R, Maris JM, Khan J. PMID: 29784674.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    8. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes. Int J Cancer. 2018 09 15; 143(6):1483-1493. Webb MW, Sun J, Sheard MA, Liu WY, Wu HW, Jackson JR, Malvar J, Sposto R, Daniel D, Seeger RC. PMID: 29665011.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    9. Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer Discov. 2018 05; 8(5):582-599. Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, Martinez D, Yarmarkovich M, Weichert-Leahey N, Abraham BJ, Alvarez MJ, Iyer A, Harenza JL, Oldridge D, De Preter K, Koster J, Asgharzadeh S, Seeger RC, Wei JS, Khan J, Vandesompele J, Mestdagh P, Versteeg R, Look AT, Young RA, Iavarone A, Lasorella A, Silva JM, Maris JM, Califano A. PMID: 29510988.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol. 2018 May; 138(1):199-207. Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G. PMID: 29427149.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    11. MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group. Oncotarget. 2018 Jan 19; 9(5):6416-6432. Niemas-Teshiba R, Matsuno R, Wang LL, Tang XX, Chiu B, Zeki J, Coburn J, Ornell K, Naranjo A, Van Ryn C, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Ikegaki N, Shimada H. PMID: 29464082.
      View in: PubMed   Mentions: 4     Fields:    
    12. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017; 6(1):1400370. Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. PMID: 29209467.
      View in: PubMed   Mentions:
    13. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. Cancer Res. 2017 09 15; 77(18):5142-5157. Borriello L, Nakata R, Sheard MA, Fernandez GE, Sposto R, Malvar J, Blavier L, Shimada H, Asgharzadeh S, Seeger RC, DeClerck YA. PMID: 28687621.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    14. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clin Cancer Res. 2017 Sep 15; 23(18):5374-5383. Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC. PMID: 28559462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles. 2017; 6(1):1294368. Jong AY, Wu CH, Li J, Sun J, Fabbri M, Wayne AS, Seeger RC. PMID: 28326171.
      View in: PubMed   Mentions:
    16. Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. Cancer. 2017 Apr 01; 123(7):1095-1105. Burchill SA, Beiske K, Shimada H, Ambros PF, Seeger R, Tytgat GA, Brock PR, Haber M, Park JR, Berthold F. PMID: 27984660.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma. Mol Ther Oncolytics. 2017 Mar 17; 4:67-76. Gutova M, Goldstein L, Metz M, Hovsepyan A, Tsurkan LG, Tirughana R, Tsaturyan L, Annala AJ, Synold TW, Wan Z, Seeger R, Anderson C, Moats RA, Potter PM, Aboody KS. PMID: 28345025.
      View in: PubMed   Mentions:
    18. Association of high microvessel avß3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 2017 Aug 08; 8(32):52193-52210. Erdreich-Epstein A, Singh AR, Joshi S, Vega FM, Guo P, Xu J, Groshen S, Ye W, Millard M, Campan M, Morales G, Garlich JR, Laird PW, Seeger RC, Shimada H, Durden DL. PMID: 28881723.
      View in: PubMed   Mentions: 2     Fields:    
    19. TGFßR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells. Clin Cancer Res. 2017 Feb 01; 23(3):804-813. Tran HC, Wan Z, Sheard MA, Sun J, Jackson JR, Malvar J, Xu Y, Wang L, Sposto R, Kim ES, Asgharzadeh S, Seeger RC. PMID: 27756784.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    20. A novel minimal residual disease model of neuroblastoma in mice. J Pediatr Surg. 2016 Jun; 51(6):991-4. Jackson JR, Kim Y, Seeger RC, Kim ES. PMID: 26995512.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    21. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma. Cancer Lett. 2016 Feb 28; 371(2):214-24. Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, Coarfa C, Tolman C, Hurd L, Liao H, He J, Wen X, Liu Z, Thiele CJ, Westermann F, Asgharzadeh S, Seeger RC, Maris JM, Guidry Auvil JM, Smith MA, Kolaczyk ED, Shohet J, Khan J. PMID: 26683771.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    22. More than the genes, the tumor microenvironment in neuroblastoma. Cancer Lett. 2016 09 28; 380(1):304-14. Borriello L, Seeger RC, Asgharzadeh S, DeClerck YA. PMID: 26597947.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    23. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell. 2015 Nov 09; 28(5):599-609. Schnepp RW, Khurana P, Attiyeh EF, Raman P, Chodosh SE, Oldridge DA, Gagliardi ME, Conkrite KL, Asgharzadeh S, Seeger RC, Madison BB, Rustgi AK, Maris JM, Diskin SJ. PMID: 26481147.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    24. Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma. Pediatr Blood Cancer. 2015 Oct; 62(10):1739-46. Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP. PMID: 26153194.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    25. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res. 2015 Aug 01; 75(15):3155-66. Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei JS, Zhang S, Gnanchandran J, Seeger R, Asgharzadeh S, Khan J, Diskin SJ, Maris JM, Cole KA. PMID: 26100672.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    26. Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study. Br J Cancer. 2015 Jun 30; 113(1):57-63. Wang LL, Teshiba R, Ikegaki N, Tang XX, Naranjo A, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Shimada H. PMID: 26035700.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    27. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7). Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri M. PMID: 25972604.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    28. Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers. Clin Cancer Res. 2015 Apr 15; 21(8):1904-15. Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger R, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M. PMID: 25231397.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    29. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group. Pediatr Dev Pathol. 2014 Nov-Dec; 17(6):441-9. Teshiba R, Kawano S, Wang LL, He L, Naranjo A, London WB, Seeger RC, Gastier-Foster JM, Look AT, Hogarty MD, Cohn SL, Maris JM, Park JR, Shimada H. PMID: 25207821.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer Cell. 2014 Sep 08; 26(3):414-427. Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, Simonds EF, Seeger R, Matthay KK, Hertz NT, Eilers M, Shokat KM, Weiss WA. PMID: 25175806.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    31. Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells. Leukemia. 2015 Apr; 29(4):788-97. Fei F, Lim M, George AA, Kirzner J, Lee D, Seeger R, Groffen J, Abdel-Azim H, Heisterkamp N. PMID: 25134458.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFß1. Cancer Immunol Immunother. 2013 Oct; 62(10):1637-48. Xu Y, Sun J, Sheard MA, Tran HC, Wan Z, Liu WY, Asgharzadeh S, Sposto R, Wu HW, Seeger RC. PMID: 23982484.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    33. Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group. Cancer. 2013 Oct 15; 119(20):3718-26. Wang LL, Suganuma R, Ikegaki N, Tang X, Naranjo A, McGrady P, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Shimada H. PMID: 23901000.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    34. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 2013 Sep; 14(10):999-1008. Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG. PMID: 23890779.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    35. Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells. J Immunother. 2013 Jun; 36(5):319-29. Sheard MA, Asgharzadeh S, Liu Y, Lin TY, Wu HW, Ji L, Groshen S, Lee DA, Seeger RC. PMID: 23719242.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    36. Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. Cancer Res. 2013 Jul 01; 73(13):3852-64. Ara T, Nakata R, Sheard MA, Shimada H, Buettner R, Groshen SG, Ji L, Yu H, Jove R, Seeger RC, DeClerck YA. PMID: 23633489.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    37. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy. Clin Cancer Res. 2013 Apr 15; 19(8):2132-43. Liu Y, Wu HW, Sheard MA, Sposto R, Somanchi SS, Cooper LJ, Lee DA, Seeger RC. PMID: 23378384.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    38. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013 Mar; 45(3):279-84. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM. PMID: 23334666.
      View in: PubMed   Mentions: 256     Fields:    Translation:HumansCells
    39. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol. 2012 Oct 01; 30(28):3525-32. Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, London WB, Sposto R, Seeger RC. PMID: 22927533.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    40. Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. Pediatr Blood Cancer. 2013 Mar; 60(3):363-70. Suganuma R, Wang LL, Sano H, Naranjo A, London WB, Seeger RC, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Jarzembowski JA, Joshi VV, Navarro S, Peuchmaur M, Shimada H. PMID: 22744966.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    41. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. Cancer Biol Ther. 2012 May; 13(7):534-41. Yang F, Jove V, Buettner R, Xin H, Wu J, Wang Y, Nam S, Xu Y, Ara T, DeClerck YA, Seeger R, Yu H, Jove R. PMID: 22406995.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    42. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res. 2012 Apr 15; 72(8):2068-78. Bosse KR, Diskin SJ, Cole KA, Wood AC, Schnepp RW, Norris G, Nguyen le B, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh EF, Mosse YP, Pineros V, Dizin E, Zhang Y, Asgharzadeh S, Seeger RC, Capasso M, Pawel BR, Devoto M, Hakonarson H, Rappaport EF, Irminger-Finger I, Maris JM. PMID: 22350409.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    43. Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene. 2012 Nov 15; 31(46):4859-67. Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, Zhao H, Guo R, Christensen JG, Orange JS, Pawel BR, Lemmon MA, Mossé YP. PMID: 22266870.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    44. Immunology and immunotherapy of neuroblastoma. Semin Cancer Biol. 2011 Oct; 21(4):229-37. Seeger RC. PMID: 21971567.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    45. Genotypes of NK cell KIR receptors, their ligands, and Fc? receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Res. 2010 Dec 01; 70(23):9554-61. Delgado DC, Hank JA, Kolesar J, Lorentzen D, Gan J, Seo S, Kim K, Shusterman S, Gillies SD, Reisfeld RA, Yang R, Gadbaw B, DeSantes KB, London WB, Seeger RC, Maris JM, Sondel PM. PMID: 20935224.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCellsCTClinical Trials
    46. Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol. 2010 Nov 20; 28(33):4969-75. Shusterman S, London WB, Gillies SD, Hank JA, Voss SD, Seeger RC, Reynolds CP, Kimball J, Albertini MR, Wagner B, Gan J, Eickhoff J, DeSantes KB, Cohn SL, Hecht T, Gadbaw B, Reisfeld RA, Maris JM, Sondel PM. PMID: 20921469.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    47. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1324-34. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM. PMID: 20879881.
      View in: PubMed   Mentions: 399     Fields:    Translation:Humans
    48. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1313-23. Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK. PMID: 20879880.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    49. Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2010 Aug 20; 28(24):3808-15. London WB, Frantz CN, Campbell LA, Seeger RC, Brumback BA, Cohn SL, Matthay KK, Castleberry RP, Diller L. PMID: 20660830.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    50. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell. 2010 Jul 23; 142(2):218-29. Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. PMID: 20655465.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    51. Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol. 2010 Jul 20; 28(21):3506-15. Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, Asgharzadeh S, Seeger R, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Vermeulen J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Weber A, Christiansen H, Grundy RG, Schardt K, Schwab M, Eils R, Warnat P, Kaderali L, Simon T, Decarolis B, Theissen J, Westermann F, Brors B, Fischer M. PMID: 20567016.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    52. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int J Cancer. 2010 Jun 01; 126(11):2622-34. Xiong G, Husseiny MI, Song L, Erdreich-Epstein A, Shackleford GM, Seeger RC, Jäckel D, Hensel M, Metelitsa LS. PMID: 19824039.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    53. Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group. Pediatr Blood Cancer. 2010 Apr; 54(4):596-602. Bensimhon P, Villablanca JG, Sender LS, Matthay KK, Park JR, Seeger R, London WB, Yap JS, Kreissman SG. PMID: 20049927.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    54. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A. 2010 Jan 26; 107(4):1506-11. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. PMID: 20080624.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    55. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG. Pediatr Blood Cancer. 2009 Oct; 53(4):563-9. Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H. PMID: 19530234.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    56. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest. 2009 Jun; 119(6):1524-36. Song L, Asgharzadeh S, Salo J, Engell K, Wu HW, Sposto R, Ara T, Silverman AM, DeClerck YA, Seeger RC, Metelitsa LS. PMID: 19411762.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansAnimalsCells
    57. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet. 2009 Jun; 41(6):718-23. Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, Mosse YP, Kim C, Diskin SJ, Cole KA, Bosse K, Diamond M, Laudenslager M, Winter C, Bradfield JP, Scott RH, Jagannathan J, Garris M, McConville C, London WB, Seeger RC, Grant SF, Li H, Rahman N, Rappaport E, Hakonarson H, Maris JM. PMID: 19412175.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    58. Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force. Br J Cancer. 2009 May 19; 100(10):1627-37. Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK. PMID: 19401690.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    59. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 2009 Apr 07; 15(4):328-40. Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R. PMID: 19345331.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    60. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol. 2009 Mar 01; 27(7):1007-13. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG. PMID: 19171716.
      View in: PubMed   Mentions: 214     Fields:    Translation:Humans
    61. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Jan; 52(1):44-50. Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK. PMID: 18937318.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    62. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 2009 Jan 01; 69(1):329-37. Ara T, Song L, Shimada H, Keshelava N, Russell HV, Metelitsa LS, Groshen SG, Seeger RC, DeClerck YA. PMID: 19118018.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    63. Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group. J Clin Oncol. 2009 Jan 01; 27(1):85-91. Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM. PMID: 19047298.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    64. An integrated cross-platform prognosis study on neuroblastoma patients. Genomics. 2008 Oct; 92(4):195-203. Chen QR, Song YK, Wei JS, Bilke S, Asgharzadeh S, Seeger RC, Khan J. PMID: 18598751.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    65. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res. 2008 Jul 15; 14(14):4572-83. Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ. PMID: 18628472.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    66. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med. 2008 Jun 12; 358(24):2585-93. Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M, Winter C, Cole KA, Glessner JT, Kim C, Frackelton EC, Casalunovo T, Eckert AW, Capasso M, Rappaport EF, McConville C, London WB, Seeger RC, Rahman N, Devoto M, Grant SF, Li H, Hakonarson H. PMID: 18463370.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    67. Cdc6 knockdown inhibits human neuroblastoma cell proliferation. Mol Cell Biochem. 2008 Apr; 311(1-2):189-97. Feng L, Barnhart JR, Seeger RC, Wu L, Keshelava N, Huang SH, Jong A. PMID: 18259842.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    68. Sparse representation and Bayesian detection of genome copy number alterations from microarray data. Bioinformatics. 2008 Feb 01; 24(3):309-18. Pique-Regi R, Monso-Varona J, Ortega A, Seeger RC, Triche TJ, Asgharzadeh S. PMID: 18203770.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    69. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene. Clin Cancer Res. 2007 Oct 15; 13(20):6001-9. Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX. PMID: 17947461.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    70. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J Clin Invest. 2007 Sep; 117(9):2702-12. Song L, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, DeClerck YA, Thiele CJ, Sposto R, Metelitsa LS. PMID: 17710228.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    71. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst. 2006 Sep 06; 98(17):1193-203. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC. PMID: 16954472.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    72. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clin Cancer Res. 2006 Mar 15; 12(6):1750-9. Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM. PMID: 16551859.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    73. The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res. 2006 Mar 01; 66(5):2826-33. Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N. PMID: 16510605.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    74. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol. 2006 Jan 20; 24(3):500-6. Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM. PMID: 16421427.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    75. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005 Nov 24; 353(21):2243-53. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM. PMID: 16306521.
      View in: PubMed   Mentions: 143     Fields:    Translation:HumansCells
    76. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J Clin Oncol. 2005 Sep 20; 23(27):6474-80. Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK. PMID: 16116154.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    77. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005 Sep 20; 23(27):6459-65. London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. PMID: 16116153.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    78. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index. Cancer. 2005 Jan 01; 103(1):174-80. Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H. PMID: 15549714.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    79. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. Cancer. 2004 Oct 15; 101(8):1873-81. Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC. PMID: 15386308.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. J Clin Oncol. 2004 Oct 15; 22(20):4127-34. Roberts SS, Mori M, Pattee P, Lapidus J, Mathews R, O'Malley JP, Hsieh YC, Turner MA, Wang Z, Tian Q, Rodland MJ, Reynolds CP, Seeger RC, Nagalla SR. PMID: 15483022.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    81. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med. 2004 May 03; 199(9):1213-21. Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB, Seeger RC. PMID: 15123743.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    82. Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer. 2003 Aug 15; 98(4):841-53. Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL. PMID: 12910530.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    83. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia. 2003 Jun; 17(6):1068-77. Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. PMID: 12764370.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    84. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys. 2003 May 01; 56(1):28-39. Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK. PMID: 12694821.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    85. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis. Blood. 2002 Jun 01; 99(11):4166-73. Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC. PMID: 12010822.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    86. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001 Nov 15; 92(10):2699-708. Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H. PMID: 11745206.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    87. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line. J Pediatr Hematol Oncol. 2001 Nov; 23(8):500-5. Anderson CP, Seeger RC, Satake N, Monforte-Munoz HL, Keshelava N, Bailey HH, Reynolds CP. PMID: 11878777.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    88. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol. 2001 Sep 15; 167(6):3114-22. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. PMID: 11544296.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    89. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow. Am J Pathol. 2001 Aug; 159(2):493-500. Hoon DS, Kuo CT, Wen S, Wang H, Metelitsa L, Reynolds CP, Seeger RC. PMID: 11485908.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    90. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol. 2001 Jun; 36(6):612-22. Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK. PMID: 11344492.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    91. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Jun; 36(6):623-9. Cooper R, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H. PMID: 11344493.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    92. Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma. J Pediatr Hematol Oncol. 2001 Mar-Apr; 23(3):150-2. Reynolds CP, Seeger RC. PMID: 11305717.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Cancer Res. 2001 Jan 15; 61(2):679-86. Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. PMID: 11212268.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    94. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol. 2001 Jan; 36(1):28-31. Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS. PMID: 11464899.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    95. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol. 2001 Jan; 36(1):32-6. Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM. PMID: 11464900.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    96. Residential pesticide exposure and neuroblastoma. Epidemiology. 2001 Jan; 12(1):20-7. Daniels JL, Olshan AF, Teschke K, Hertz-Picciotto I, Savitz DA, Blatt J, Bondy ML, Neglia JP, Pollock BH, Cohn SL, Look AT, Seeger RC, Castleberry RP. PMID: 11138814.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    97. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma. Med Pediatr Oncol. 2001 Jan; 36(1):24-7. Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM. PMID: 11464895.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    98. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. J Clin Oncol. 2000 Dec 15; 18(24):4077-85. Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC. PMID: 11118469.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCTClinical Trials
    99. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol. 2000 Dec 15; 18(24):4067-76. Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK. PMID: 11118468.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    100. Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors. Med Pediatr Oncol. 2000 Dec; 35(6):619-22. Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC, Reynolds CP. PMID: 11107131.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    101. Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol. 2000 Dec; 35(6):647-50. Choi LM, Kim NW, Zuo JJ, Gerbing R, Stram D, Lukens JN, Matthay KK, Seeger RC, Reynolds CP. PMID: 11107138.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    102. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer. 2000 Sep 01; 89(5):1150-61. Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H. PMID: 10964346.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Parental smoking and alcohol consumption and risk of neuroblastoma. Cancer Epidemiol Biomarkers Prev. 2000 Sep; 9(9):967-72. Yang Q, Olshan AF, Bondy ML, Shah NR, Pollock BH, Seeger RC, Look AT, Cohn SL. PMID: 11008916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    104. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):315-20. Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J. PMID: 10959901.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    105. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol. 2000 May; 18(9):1888-99. Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. PMID: 10784629.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    106. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol. 2000 Mar; 18(6):1260-8. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK. PMID: 10715296.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    107. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol. 2000 Feb; 18(3):477-86. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J. PMID: 10653863.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    108. Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating. Cancer Immunol Immunother. 2000 Feb; 48(11):603-12. Chen RL, Reynolds CP, Seeger RC. PMID: 10663607.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    109. Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors. Clin Cancer Res. 2000 Feb; 6(2):551-8. Wang Y, Einhorn P, Triche TJ, Seeger RC, Reynolds CP. PMID: 10690538.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    110. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 2000 Feb 01; 60(3):712-21. Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL. PMID: 10676658.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    111. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol. 2000 Jan; 18(1):18-26. Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN. PMID: 10623689.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    112. Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Am J Epidemiol. 1999 Nov 01; 150(9):930-8. Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, Seeger RC, Look AT, Cohn SL, Castleberry RP, Bondy ML. PMID: 10547138.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    113. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999 Oct 14; 341(16):1165-73. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. PMID: 10519894.
      View in: PubMed   Mentions: 409     Fields:    Translation:HumansCTClinical Trials
    114. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999 Sep 02; 18(35):4948-57. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM. PMID: 10490829.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    115. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst. 1999 Jul 07; 91(13):1138-46. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP. PMID: 10393722.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    116. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol. 1999 May-Jun; 21(3):181-9. DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, Haase GM, Black CT, Perez C, Shimada H, Gerbing R, Stram DO, Matthay KK. PMID: 10363850.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    117. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. Cancer Res. 1999 Mar 15; 59(6):1327-36. Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA. PMID: 10096567.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    118. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res. 1998 Dec 01; 58(23):5396-405. Keshelava N, Seeger RC, Groshen S, Reynolds CP. PMID: 9850071.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    119. Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma. Med Pediatr Oncol. 1998 Jun; 30(6):339-46. Goldberg SS, DeSantes K, Huberty JP, Price D, Hasegawa BH, Reynolds CP, Seeger RC, Hattner R, Matthay KK. PMID: 9589082.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    120. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 1998 May 15; 58(10):2209-16. Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. PMID: 9605768.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    121. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol. 1998 Apr; 16(4):1256-64. Matthay KK, Perez C, Seeger RC, Brodeur GM, Shimada H, Atkinson JB, Black CT, Gerbing R, Haase GM, Stram DO, Swift P, Lukens JN. PMID: 9552023.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    122. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors. J Clin Oncol. 1998 Mar; 16(3):937-44. Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC. PMID: 9508176.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    123. A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma. Hum Gene Ther. 1998 Feb 10; 9(3):379-90. Seeger RC, Rosenblatt JD, Duerst RE, Reynolds CP, Villablanca JG, Hasenauer B, Feig SA. PMID: 9508055.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    124. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol. 1998 Jan; 16(1):229-36. Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin A, Reynolds CP, Seeger RC, Weinberg VK, Price D. PMID: 9440747.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    125. Telomerase expression in primary neuroblastomas. Eur J Cancer. 1997 Oct; 33(12):1929-31. Reynolds CP, Zuo JJ, Kim NW, Wang H, Lukens JN, Matthay KK, Seeger RC. PMID: 9516826.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    126. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer. 1997 Oct; 33(12):2113-6. Castleberry RP, Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee RE, Matthay KK, Michon JM, Monclair R, Roald BR, Seeger RC, Shaw PJ, Shuster JJ. PMID: 9516864.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    127. Drug resistance in human neuroblastoma cell lines correlates with clinical therapy. Eur J Cancer. 1997 Oct; 33(12):2002-6. Keshelava N, Seeger RC, Reynolds CP. PMID: 9516842.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    128. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer. 1997 Jul 15; 80(2):317-33. Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM. PMID: 9217046.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCTClinical Trials
    129. Wild-type DNA sequence of the N-myc transactivation domain in human neuroblastoma. Int J Cancer. 1997 Jun 11; 71(6):1116-7. Feng L, Miyake M, Seeger RC, Bogenmann E. PMID: 9185720.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    130. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer. 1997 May 15; 79(10):2028-35. Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK. PMID: 9149032.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    131. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 1997 Jan; 150(1):81-9. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. PMID: 9006325.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    132. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol. 1996 Sep; 14(9):2417-26. Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Brodeur GM, Seeger RC. PMID: 8823319.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    133. Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience. Ann Surg Oncol. 1995 Nov; 2(6):516-23. Haase GM, O'Leary MC, Stram DO, Lukens JN, Seeger RC, Shimada H, Matthay KK. PMID: 8591082.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    134. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst. 1995 Oct 04; 87(19):1470-6. Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC. PMID: 7674334.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    135. Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector. Cancer Gene Ther. 1995 Sep; 2(3):171-81. Uçar K, Seeger RC, Challita PM, Watanabe CT, Yen TL, Morgan JP, Amado R, Chou E, McCallister T, Barber JR. PMID: 8528960.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    136. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res. 1995 Aug 01; 55(15):3386-8. Wada M, Seeger RC, Mizoguchi H, Koeffler HP. PMID: 7614476.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    137. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol. 1995 Apr; 13(4):894-901. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP. PMID: 7707116.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    138. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results. Eur J Cancer. 1995; 31A(4):572-5. Matthay KK, O'Leary MC, Ramsay NK, Villablanca J, Reynolds CP, Atkinson JB, Haase GM, Stram DO, Seeger RC. PMID: 7576971.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    139. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group. Blood. 1994 Nov 15; 84(10):3465-72. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC. PMID: 7524740.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    140. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. J Clin Oncol. 1994 Nov; 12(11):2382-9. Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary MC, Harris RE, Selch M, Atkinson JB, Haase GM, Ramsay NK. PMID: 7964954.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    141. Bone abnormalities detected with skeletal scintigraphy after bone marrow harvest in patients with childhood neuroblastoma. Radiology. 1994 Sep; 192(3):755-8. Ortiz SS, Miller JH, Villablanca JG, Seeger RC. PMID: 8058943.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    142. Hsp27 expression in neuroblastoma: correlation with disease stage. J Natl Cancer Inst. 1994 May 18; 86(10):780-4. Ungar DR, Hailat N, Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds CP, Hanash SM. PMID: 8169976.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    143. Human dTMP kinase: gene expression and enzymatic activity coinciding with cell cycle progression and cell growth. DNA Cell Biol. 1994 May; 13(5):461-71. Huang SH, Tang A, Drisco B, Zhang SQ, Seeger R, Li C, Jong A. PMID: 8024690.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    144. Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro. J Immunother Emphasis Tumor Immunol. 1994 Jan; 15(1):29-37. Hank JA, Surfus J, Gan J, Chew TL, Hong R, Tans K, Reisfeld R, Seeger RC, Reynolds CP, Bauer M. PMID: 8110728.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    145. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification. Cancer Detect Prev. 1994; 18(4):283-9. Tanaka T, Seeger RC, Tanabe M, Hiyama E, Shimoda H, Ida N. PMID: 7982238.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    146. Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma. Prog Clin Biol Res. 1994; 385:287-91. Stram DO, Matthay KK, O'Leary M, Reynolds CP, Seeger RC. PMID: 7972222.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    147. Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma. Prog Clin Biol Res. 1994; 385:301-7. Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary M, Harris RE, Selch M, Atkinson JB, Haase G, Hammond GD. PMID: 7972225.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma. Prog Clin Biol Res. 1994; 385:163-8. Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC. PMID: 7972208.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    149. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer. 1993 Dec 01; 72(11):3346-54. Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP. PMID: 8242562.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    150. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study. J Clin Oncol. 1993 Nov; 11(11):2226-33. Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC. PMID: 8229138.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    151. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes Cancer. 1993 May; 7(1):32-7. Srivatsan ES, Ying KL, Seeger RC. PMID: 7688553.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    152. Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma. J Clin Oncol. 1993 Apr; 11(4):623-9. Campbell LA, Seeger RC, Harris RE, Villablanca JG, Matthay KK. PMID: 8478657.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 1993 Apr; 8(4):855-65. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS. PMID: 8384356.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    154. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst. 1993 Mar 03; 85(5):377-84. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. PMID: 8433391.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    155. PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors. Clin Exp Metastasis. 1993 Jan; 11(1):83-90. Keim DR, Hailat N, Kuick R, Reynolds CP, Brodeur GM, Seeger RC, Hanash SM. PMID: 8093685.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    156. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol. 1992 Dec; 1(4):229-34. Crabbe DC, Peters J, Seeger RC. PMID: 1342970.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    157. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Oncogene. 1992 Apr; 7(4):711-7. Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland C, Black AC, Rosenblatt JD. PMID: 1565467.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    158. A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases. Cancer. 1991 Sep 15; 68(6):1296-302. Tanaka T, Slamon DJ, Shimada H, Shimoda H, Fujisawa T, Ida N, Seeger RC. PMID: 1873783.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    159. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg. 1991 Sep; 26(9):1119-23; discussion 1123-4. Haase GM, O'Leary MC, Ramsay NK, Romansky SG, Stram DO, Seeger RC, Hammond GD. PMID: 1941492.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    160. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991 Jul; 88(1):341-5. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR. PMID: 2056128.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    161. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am. 1991 Apr; 38(2):393-424. Seeger RC, Reynolds CP. PMID: 2006084.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    162. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med. 1991 Jan 24; 324(4):219-26. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. PMID: 1985243.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    163. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res. 1991; 366:203-11. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC. PMID: 2068138.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    164. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res. 1991; 366:527-33. Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, Selch M, Ramsay N, Reynolds CP. PMID: 2068169.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    165. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog Clin Biol Res. 1991; 366:91-8. Srivatsan ES, Murali V, Seeger RC. PMID: 2068183.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    166. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene. 1990 Nov; 5(11):1615-8. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC, Reynolds CP, Hanash S. PMID: 2267130.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    167. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors. Cancer Res. 1990 Sep 15; 50(18):6055-61. Cohen PS, Cooper MJ, Helman LJ, Thiele CJ, Seeger RC, Israel MA. PMID: 2393870.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    168. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. J Clin Invest. 1990 May; 85(5):1555-9. Hsiao RJ, Seeger RC, Yu AL, O'Connor DT. PMID: 2332506.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    169. A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal. J Pediatr Surg. 1989 Apr; 24(4):386-90. Smith EI, Haase GM, Seeger RC, Brodeur GM. PMID: 2732883.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    170. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 1989 Feb; 7(2):236-44. Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD. PMID: 2915240.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    171. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988 Dec; 6(12):1874-81. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI. PMID: 3199170.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    172. Expression of a developmental stage-specific antigen by neuronal precursor cells of human fetal cerebellum. J Neuroimmunol. 1988 Nov; 20(1):3-14. Moss TJ, Rosenblatt HM, Seeger RC. PMID: 3183035.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    173. Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization. Am J Pathol. 1988 Jun; 131(3):391-7. Cohen PS, Seeger RC, Triche TJ, Israel MA. PMID: 2454580.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    174. Characterization of N-myc amplification units in human neuroblastoma cells. Mol Cell Biol. 1988 Feb; 8(2):522-30. Zehnbauer BA, Small D, Brodeur GM, Seeger R, Vogelstein B. PMID: 2832725.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    175. Bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res. 1988; 271:203-13. Seeger RC, Moss TJ, Feig SA, Lenarsky C, Selch M, Ramsay N, Harris R, Wells J, Sather H, Reynolds CP. PMID: 3043448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    176. Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas. Prog Clin Biol Res. 1988; 271:3-15. Brodeur GM, Fong CT, Morita M, Griffith R, Hayes FA, Seeger RC. PMID: 3043452.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    177. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res. 1988; 271:291-306. Reynolds CP, Tomayko MM, Donner L, Helson L, Seeger RC, Triche TJ, Brodeur GM. PMID: 3406003.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    178. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res. 1988; 271:41-9. Seeger RC, Wada R, Brodeur GM, Moss TJ, Bjork RL, Sousa L, Slamon DJ. PMID: 3406010.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    179. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. Prog Clin Biol Res. 1988; 271:509-24. Brodeur GM, Seeger RC, Barrett A, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G. PMID: 3406015.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    180. N-myc protein expression by neuroblastoma cells that have metastasized to bone marrow. Prog Clin Biol Res. 1988; 271:91-101. Moss TJ, Law YM, Slamon DJ, Brodeur GM, Seeger RC. PMID: 3406026.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    181. Characterization of human neuroblastoma cell lines that lack N-myc gene amplification. Prog Clin Biol Res. 1988; 271:57-69. Wada RK, Seeger RC, Brodeur GM, Slamon DJ, Rayner SA, Tomayko M, Reynolds CP. PMID: 3406020.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    182. Oncogenes in clinical cancer--a panel discussion. Breast Cancer Res Treat. 1987 Dec; 10(3):217-27. McGuire WL, Johnson BE, Seeger RC, Slamon DJ. PMID: 2833962.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. Delayed surgery and bone marrow transplantation for widespread neuroblastoma. Ann Surg. 1987 Oct; 206(4):514-20. Moss TJ, Fonkalsrud EW, Feig SA, Lenarsky C, Selch M, Wells J, Seeger RC. PMID: 3310932.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    184. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987 Aug 15; 47(16):4248-53. Brodeur GM, Hayes FA, Green AA, Casper JT, Wasson J, Wallach S, Seeger RC. PMID: 2440561.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    185. Shedding of GD2 ganglioside by human neuroblastoma. Int J Cancer. 1987 Jan 15; 39(1):73-6. Ladisch S, Wu ZL, Feig S, Ulsh L, Schwartz E, Floutsis G, Wiley F, Lenarsky C, Seeger R. PMID: 3539825.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    186. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man. Prog Clin Biol Res. 1987; 244:371-90. Butturini A, Bortin MM, Seeger RC, Gale RP. PMID: 3310000.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    187. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res. 1986 Nov; 46(11):5882-6. Reynolds CP, Seeger RC, Vo DD, Black AT, Wells J, Ugelstad J. PMID: 3756928.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    188. Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood. 1986 Oct; 68(4):954-6. Butturini A, Seeger RC, Gale RP. PMID: 2944556.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    189. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Cancer Res. 1986 Oct; 46(10):5297-301. Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt F, Latt SA. PMID: 3756879.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    190. Clinical implications of oncogene activation in human neuroblastomas. Cancer. 1986 Jul 15; 58(2 Suppl):541-5. Brodeur GM, Seeger RC, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. PMID: 3719548.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    191. Identification and characterization of the protein encoded by the human N-myc oncogene. Science. 1986 May 09; 232(4751):768-72. Slamon DJ, Boone TC, Seeger RC, Keith DE, Chazin V, Lee HC, Souza LM. PMID: 3008339.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    192. Amplification units containing human N-myc and c-myc genes. Proc Natl Acad Sci U S A. 1986 Feb; 83(4):1031-5. Kinzler KW, Zehnbauer BA, Brodeur GM, Seeger RC, Trent JM, Meltzer PS, Vogelstein B. PMID: 3006024.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    193. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet Cytogenet. 1986 Jan 01; 19(1-2):101-11. Brodeur GM, Seeger RC. PMID: 3940169.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    194. Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res. 1986 Jan; 46(1):440-3. Wu ZL, Schwartz E, Seeger R, Ladisch S. PMID: 3940209.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    195. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads. Prog Clin Biol Res. 1986; 211:285-93. Seeger RC, Vo DD, Ugelstad J, Reynolds CP. PMID: 3515362.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    196. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985 Oct 31; 313(18):1111-6. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. PMID: 4047115.
      View in: PubMed   Mentions: 383     Fields:    Translation:Humans
    197. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res. 1985 Jun; 45(6):2843-8. Hann HW, Evans AE, Siegel SE, Wong KY, Sather H, Dalton A, Hammond D, Seeger RC. PMID: 3986811.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    198. Immunodiagnosis and immunotherapy of childhood malignancies. Pediatr Clin North Am. 1985 Jun; 32(3):575-99. Bernstein I, Kersey J, Seeger R, Andrews R. PMID: 3889799.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    199. Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci U S A. 1985 Jun; 82(11):3761-5. Shiloh Y, Shipley J, Brodeur GM, Bruns G, Korf B, Donlon T, Schreck RR, Seeger R, Sakai K, Latt SA. PMID: 3858848.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    200. Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage. Prog Clin Biol Res. 1985; 175:105-13. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. PMID: 3991726.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    201. Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures. Prog Clin Biol Res. 1985; 175:425-41. Reynolds CP, Moss TJ, Seeger RC, Black AT, Woody JN. PMID: 2581273.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    202. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation. Cancer Res. 1985 Jan; 45(1):358-64. Sugimoto T, Sawada T, Negoro S, Kidowaki T, Morioka H, Matsumura T, Kemshead JT, Seeger RC. PMID: 2981159.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    203. Analysis of neuroblastoma cell proteins using two-dimensional electrophoresis. Prog Clin Biol Res. 1985; 175:261-8. Hanash SM, Gagnon M, Seeger RC, Baier L. PMID: 3991732.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    204. Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma. Prog Clin Biol Res. 1985; 175:319-29. Zeltzer PM, Marangos PJ, Sather H, Evans A, Siegel S, Wong KY, Dalton A, Seeger R, Hammond D. PMID: 3991735.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    205. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies. Prog Clin Biol Res. 1985; 175:347-66. Donner L, Triche TJ, Israel MA, Seeger RC, Reynolds CP. PMID: 3991736.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    206. Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens. Prog Clin Biol Res. 1985; 175:367-78. Moss TJ, Seeger RC, Kindler-Rohrborn A, Marangos PJ, Rajewsky MF, Reynolds CP. PMID: 3991737.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    207. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads. Prog Clin Biol Res. 1985; 175:443-58. Seeger RC, Reynolds CP, Vo DD, Ugelstad J, Wells J. PMID: 3887429.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    208. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study. Prog Clin Biol Res. 1985; 175:557-63. D'Angio GJ, August C, Elkins W, Evans AE, Seeger R, Lenarsky C, Feig S, Wells J, Ramsay N, Kim T. PMID: 3887431.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    209. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984 Jun 08; 224(4653):1121-4. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. PMID: 6719137.
      View in: PubMed   Mentions: 480     Fields:    Translation:HumansCells
    210. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res. 1983 Oct; 148(1):21-30. Sidell N, Altman A, Haussler MR, Seeger RC. PMID: 6313408.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    211. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group. Lancet. 1983 Aug 13; 2(8346):361-3. Zeltzer PM, Marangos PJ, Parma AM, Sather H, Dalton A, Hammond D, Siegel SE, Seeger RC. PMID: 6135871.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    212. Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid. Ann Intern Med. 1982 Dec; 97(6):873-84. Seeger RC, Siegel SE, Sidell N. PMID: 6756240.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    213. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol. 1982 Feb; 128(2):983-9. Seeger RC, Danon YL, Rayner SA, Hoover F. PMID: 6172518.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    214. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res. 1981 Jul; 41(7):2714-7. Seeger RC, Rosenblatt HM, Imai K, Ferrone S. PMID: 6166367.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    215. Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies. J Natl Cancer Inst. 1981 May; 66(5):827-9. Howe AJ, Seeger RC, Molinaro GA, Ferrone S. PMID: 6262557.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    216. In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma. Cancer Treat Rep. 1980 Aug-Sep; 64(8-9):975-9. Siegel MM, Chung HS, Rucker N, Siegel SE, Seeger RC, Isaacs H, Benedict WF. PMID: 7448832.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    217. Fetal neural antigens on human neuroblastoma cells. J Immunol. 1980 Jun; 124(6):2925-9. Danon YL, Seeger RC, Maidman JE. PMID: 6246171.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    218. Volumetric and functional heterogeneity of human monocytes. J Clin Invest. 1980 Mar; 65(3):613-8. Arenson EB, Epstein MB, Seeger RC. PMID: 7354131.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    219. Variability in DNA distributions of human neuroblastomas after cyclophosphamide. Cancer Treat Rep. 1980; 64(12):1275-81. Danon YL, Epstein MB, Siegel MM, Rucker N, Myers CP, Norman A, Benedict WF, Seeger RC. PMID: 7471116.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    220. Onco-neural antigen: a new neural differentiation antigen expressed by neuroblastoma, oat cell carcinoma, Wilms' tumor, and sarcoma cells. J Immunol. 1979 Apr; 122(4):1548-55. Seeger RC, Zeltzer PM, Rayner SA. PMID: 221577.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    221. New neural cell lines derived from experimentally induced rat tumors and from human neuroblastomas. Natl Cancer Inst Monogr. 1978 May; (48):355-7. Herschman HR, Seeger R, West G, Stahn R, Uki J. PMID: 34797.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    222. Interspecies neural membrane antigens on cultured human and murine neuroblastoma cells. J Immunol. 1977 Jun; 118(6):1995-2003. Akeson R, Seeger RC. PMID: 68077.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    223. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res. 1977 May; 37(5):1364-71. Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB, Benedict WF. PMID: 856461.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    224. Abnormalities of the immune system in children with neuroblastoma related to the neoplasm and chemotherapy. J Pediatr. 1977 Apr; 90(4):548-54. Chung HS, Higgins GR, Siegel SE, Seeger RC. PMID: 320298.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    225. Inhibition of antibody-dependent cellular cytotoxicity by protein A from Staphylococcus aureus. J Immunol. 1977 Mar; 118(3):981-5. Rosenblatt J, Zeltzer PM, Portaro J, Seeger RC. PMID: 300395.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    226. Microassay using radioiodinated protein A from Staphylococcus aureus for antibodies bound to cell surface antigens of adherent tumor cells. J Immunol Methods. 1977; 17(1-2):163-75. Zeltzer PM, Seeger RC. PMID: 903615.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    227. Disease and non-disease-related cell-mediated cytotoxicity in humans. Cancer Res. 1976 Apr; 36(4):1361-6. Bloom ET, Seeger RC. PMID: 1260761.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    228. Anti-tumour cytotoxic effects mediated by minor and major cell populations of lymph nodes. Nature. 1974 Nov 29; 252(5482):420-1. Seeger RC, Owen JJ. PMID: 4547827.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    229. An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas. Int J Cancer. 1974 May 15; 13(5):697-713. Seeger RC, Rayner SA, Owen JJ. PMID: 4367342.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    230. Immunity to tumours of the murine leukaemia-sarcoma virus complex. Br J Cancer Suppl. 1973 Aug; 1:26-34. Owen JJ, Seeger RC. PMID: 4374230.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    231. [Antitumor activity of phallolysin from Amanita phalloides (author's transl)]. Naunyn Schmiedebergs Arch Pharmacol. 1973; 279(3):235-42. Seeger R, Lehmann D. PMID: 4270744.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    232. Macrophage-bound antigens. II. Comparison of the immunogenicity of antigens bound to macrophages, lymphocytes, thymocytes and hepatoma cells. J Immunol. 1972 Aug; 109(2):255-61. Seeger RC, Oppenheim JJ. PMID: 4340083.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    233. Macrophage-bound antigens. I. Induction of delayed hypersensitivity and priming for production of serum antibodies in guinea pigs. J Immunol. 1972 Aug; 109(2):244-54. Seeger RC, Oppenheim JJ. PMID: 5047370.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCellsPHPublic Health
    234. Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes. J Exp Med. 1970 Jul 01; 132(1):44-65. Seeger RC, Oppenheim JJ. PMID: 4994445.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    Robert's Networks
    Concepts (752)
    Derived automatically from this person's publications.
    Co-Authors (41)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department